Release Date: 30/11/09 17:12 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 94.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%